Clinical Nuclear Medicine

Skip Navigation LinksHome > April 2013 - Volume 38 - Issue 4 > 18F-FDG PET/CT for the Assessment of Disease Extension and A...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31827a27df
Original Articles

18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study

Ambrosini, Valentina MD, PhD*; Zompatori, Maurizio MD; Fasano, Luca MD; Nanni, Cristina MD*; Nava, Stefano MD; Rubello, Domenico MD§; Fanti, Stefano MD*

Collapse Box


Purpose: This study aimed to prospectively investigate 18F-FDG PET/CT role for the assessment of sarcoidosis activity and extension in comparison with thoracic high-resolution CT (HRCT) and to evaluate the potential clinical impact of PET/CT findings. Secondary aim was to investigate the changes in cardiac FDG uptake related to the specific preparation before PET/CT.

Methods: We prospectively enrolled biopsy proven sarcoidosis patients consecutively referred for 18F-FDG PET/CT since January 2010. PET/CT was performed after a fat meal followed by 12-hour fasting and compared with thoracic HRCT results obtained in supine position and clinical follow-up. The impact on the clinical management was recorded.

Patterns of cardiac FDG uptake of the study group were compared with a historical population in which PET/CT was performed following standard preparation.

Results: A total of 28 patients were enrolled, and 35 PET/CT scans were reviewed. On a scan basis, PET/CT was concordant with HRCT in 16 (45.7%), detecting active disease in 10/16 and no signs of activity in 4/16. PET/CT data had a direct impact on management in 4/16.

In 19 (54.3%) discordant scans, PET/CT finding was positive in 14 and negative in 5. PET/CT findings influenced the clinical management in 18/19 cases.

Considering all scans, PET/CT information influenced the clinical management of 22 (63%) of 35.

Our data suggest that cardiac FDG uptake may vary regardless of the preparation before PET/CT.

Conclusions: 18F-FDG PET/CT was useful to assess sarcoidosis activity and extension and provided valuable information for the clinical management in a single-step examination. Additional data are needed to better ascertain the optimal patient preparation before image acquisition to improve sensitivity of heart lesions.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.